Similar articles for PMID: 21740673

Year	Number of Results
1992	1
1993	1
1996	2
1997	1
1999	1
2000	1
2002	1
2003	2
2004	1
2005	1
2006	4
2007	8
2008	5
2009	7
2010	12
2011	6
2012	6
2013	6
2014	7
2015	13
2016	10
2017	3
2018	2
2019	3
2020	2
2021	2
2022	2
2024	0

1

Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality.

von Reyn CF, Kimambo S, Mtei L, Arbeit RD, Maro I, Bakari M, Matee M, Lahey T, Adams LV, Black W, Mackenzie T, Lyimo J, Tvaroha S, Waddell R, Kreiswirth B, Horsburgh CR, Pallangyo K. von Reyn CF, et al. Int J Tuberc Lung Dis. 2011 Aug;15(8):1087-92. doi: 10.5588/ijtld.10.0517. Int J Tuberc Lung Dis. 2011. PMID: 21740673 Free PMC article.

2

Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.

Matee M, Lahey T, Vuola JM, Mtei L, Cole BF, Bakari M, Arbeit RD, Horsburgh CR, Pallangyo K, von Reyn CF. Matee M, et al. J Infect Dis. 2007 Jan 1;195(1):118-23. doi: 10.1086/509896. Epub 2006 Nov 20. J Infect Dis. 2007. PMID: 17152015 Free PMC article.

3

Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.

Lahey T, Matee M, Mtei L, Bakari M, Pallangyo K, von Reyn CF. Lahey T, et al. BMC Infect Dis. 2009 Feb 23;9:21. doi: 10.1186/1471-2334-9-21. BMC Infect Dis. 2009. PMID: 19236695 Free PMC article. Clinical Trial.

4

High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.

Jiang W, Shao L, Zhang Y, Zhang S, Meng C, Xu Y, Huang L, Wang Y, Wang Y, Weng X, Zhang W. Jiang W, et al. BMC Immunol. 2009 May 28;10:31. doi: 10.1186/1471-2172-10-31. BMC Immunol. 2009. PMID: 19476627 Free PMC article.

5

Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.

Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC. Nakiyingi L, et al. BMC Infect Dis. 2015 Feb 15;15:62. doi: 10.1186/s12879-015-0812-4. BMC Infect Dis. 2015. PMID: 25888317 Free PMC article.

6

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.

von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T, Matee M, Bakari M, Tvaroha S, Adams LV, Horsburgh CR, Pallangyo K; DarDar Study Group. von Reyn CF, et al. AIDS. 2010 Mar 13;24(5):675-85. doi: 10.1097/QAD.0b013e3283350f1b. AIDS. 2010. PMID: 20118767 Free PMC article. Clinical Trial.

7

Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.

Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Miles DJ, et al. Immunology. 2010 Mar;129(3):446-54. doi: 10.1111/j.1365-2567.2009.03186.x. Epub 2009 Dec 2. Immunology. 2010. PMID: 20002789 Free PMC article.

8

Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Lahey T, Sheth S, Matee M, Arbeit R, Horsburgh CR, Mtei L, Mackenzie T, Bakari M, Vuola JM, Pallangyo K, von Reyn CF. Lahey T, et al. J Infect Dis. 2010 Oct 15;202(8):1265-72. doi: 10.1086/656332. J Infect Dis. 2010. PMID: 20812851 Free PMC article. Clinical Trial.

9

Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.

Nemes E, Hesseling AC, Tameris M, Mauff K, Downing K, Mulenga H, Rose P, van der Zalm M, Mbaba S, Van As D, Hanekom WA, Walzl G, Scriba TJ, McShane H, Hatherill M; MVA029 Study Team. Nemes E, et al. Clin Infect Dis. 2018 Feb 1;66(4):554-563. doi: 10.1093/cid/cix834. Clin Infect Dis. 2018. PMID: 29028973 Free PMC article. Clinical Trial.

10

Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.

Clark SA, Martin SL, Pozniak A, Steel A, Ward B, Dunning J, Henderson DC, Nelson M, Gazzard B, Kelleher P. Clark SA, et al. Clin Exp Immunol. 2007 Nov;150(2):238-44. doi: 10.1111/j.1365-2249.2007.03477.x. Epub 2007 Aug 2. Clin Exp Immunol. 2007. PMID: 17672869 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year